Abstract
Fish and fish oils contain the omega-3 fatty acids known as eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA). Epidemiological studies have shown an inverse relation between the dietary consumption of fish containing EPA/DHA and mortality from coronary heart disease. These relationships have been substantiated from blood measures of omega-3 fatty acids including DHA as a physiological biomarker for omega-3 fatty acid status. Controlled intervention trials with fish oil supplements enriched in EPA/DHA have shown their potential to reduce mortality in post-myocardial infarction patients with a substantial reduction in the risk of sudden cardiac death. The cardioprotective effects of EPA/DHA are widespread, appear to act independently of blood cholesterol reduction, and are mediated by diverse mechanisms. Their overall effects include anti-arrhythmic, blood triglyceride-lowering, anti-thrombotic, anti-inflammatory, endothelial relaxation, plus others. Current dietary intakes of EPA/DHA in North America and elsewhere are well below those recommended by the American Heart Association for the management of patients with coronary heart disease. (Mol Cell Biochem 263: 217–225, 2004)
Similar content being viewed by others
References
Schmidt EB, Skou HA, Christensen JH, Dyerberg J: n-3 Fatty acids from fish and coronary artery disease: Implications for public health. Public Health Nutr 31: 91–98, 2000
Angerer P, von Schacky C: N-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol 11: 57–63, 2000
Connor WE: Importance on n-3 fatty acids in health and disease. Am J Clin Nutr 71(suppl 1): 171–175, 2000
Holub BJ: Clinical nutrition. 4. Omega-3 fatty acids in cardiovascular care. JAMC 166: 608–615, 2002
Raper NR, Cronin FJ, Exler J: Fatty acid content in the US food supply. J AmColl Nutr 11: 304–308, 1992
Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, et al.: Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71(suppl 1): 179–188, 2000
Health and Welfare Canada: Nutrient recommendations: The Report of the Scientific Review Committee. Supply and Services Canada, Ottawa, 1990
de Lorgeril M, Salen P, Martin J-L, Monjaud I, Delaye J, Mamelle N: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Heart Diet Study. Circulation 99: 779–785, 1999
Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, Hennekens CH, Willet WC: Dietary intake of α-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69: 890–897, 1999
Oomen CM, Ocke MC, Feskens E, Kok FJ, Kromhout D: α–Linolenic acid intake is not beneficially associated with 10-yr risk of coronary artery disease incidence: The Zutphen Elderly Study. Am J Clin Nutr 74: 457–463, 2001
Djousse L, Folsom AR, Province MA, Hunt SC, Ellison RC: National Heart, Lung and Blood Institute Family Heart Study. Dietary linolenic acid and carotid atherosclerosis: The National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 77: 819–825, 2003
Chan JK, McDonald BE, Gerrard JM, Bruce VM, Weaver BJ, Holub BJ: Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis. Lipids 28: 811–817, 1993
Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic acid in young adult males. Biochim Biophys Acta 1213: 277–288, 1994
Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docos-apentaenoic acids are the principle products of alpha-linolenic acid metabolism in young men. Br J Nutr 88: 355–363, 2002
Burdge GC, Wootton SA: Conversion of alpha-linolenic acid to eicos-apentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88: 411–420, 2002
Cunnane SC, Francescutti V, Brenna JT, Crawford MA: Breast-fed infants achieve a higher rate of brain and whole body docosahexanoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 35: 105–111, 2000
Bang HO, Dyerburg J: Lipid metabolism and ischemic heart disease in Greenland Eskimos. In: H.H. Draper (ed). Advances in Nutrition Research. Plenum Press, New York, 1980, pp. 1–22
Jacobs HL, Kahn HD, Stralka KA, Phan DB: Estimates of per capita fish consumption in the U.S. based on the continuing survey of food intake by individuals (CSFII). Risk Anal 18: 283–291, 1998.225
He K, Rimm EB, Merchant A, Rosner BA, Stampfer MJ, Willet WC, Ascherio A: Fish consumption and risk of stroke in men. JAMA 288: 3130–3136, 2002
Dolecek TA: Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. PSEBM 200: 177–182, 1992
von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H: The effect of dietary ù-3 fatty acids on coronary atherosclerosis: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130: 554–562, 1999
GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and Vitamin E after myocardial infarction: results of the GSSI-Prevenzione trial. Lancet 354: 447–455, 1999
Leaf A, Kang JX, Xiao Y-F, Billman GE, Voskuyl RA: The antiarrhyth-mic and anticonvulsant effects of dietary n-3 fatty acids. J Membr Biol 172: 1–11, 1999
Harris WS: Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30: 785–807, 1989
Kastelein J: What future for combination therapies? Int J Clin Pract Suppl 134: 45–50, 2003
Maresta A, Balducceli M, Varani E, Marzilli M, Galli C, Heiman F, Lavezzari M, Stragliotto E, DeCaterina R: Prevention of postcoro-nary angioplasty restenosis by omega-3 fatty acids: Main results of the Esapent for Prevention of Restenosis Italian Study ( ESPIRIT). Am Heart J 143: e5, 2002
Thies F, Garry JMC, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallaher PJ, Calder PC, Grimble RF: Association of n-3 polyunsatu-rated fatty acids with stability of atherosclerotic plaques: A randomized controlled trial. Lancet 361: 477–485, 2003
Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT, Hulley SB: Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 142: 469–476, 1995
Dewailly E, Blanchet C, Lemieux S, Sauve L, Gingras S, Ayotte P, Holub BJ: N-3 fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74: 464–473, 2001
Albert CM, Campos H, Stampfer MJ, Rider PM, Manson JAE, Willett WC, Ma J: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113–1118, 2002
Brouwer IA, Zock PL, van Amelsvoort LGPM, Katan MB, Schouten EG: Association between n-3 fatty acid status in blood and electrocar-diographic predictors of arrhythmia risk in healthy volunteers. Am J Cardiol 89: 629–631, 2002
Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscov-ick DS: n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Am J Clin Nutr 77: 319–325, 2003
Harris WS: N-3 long-chain polyunsaturated fatty acids reduce risk of coronary heart disease: Extending the evidence to the elderly. AmJ Clin Nutr 77: 279–280, 2003
O'Connor CM, Gurbel PA, Serebruany VL: Depression and ischemic heart disease. Am Heart J 140(suppl 4): 63–69, 2000
Shiotani I, Sato H, Kinjo K, Nakatani D, Mizuno H, Ohnishi Y, Hishida E, Kijima Y, Hori M, Sato H: Osaka Acute Coronary Insufficiency Study (OACIS) Group. Depressive symptoms predict 12-month prognosis in elderly patients with acute myocardial infarction. J Cardiovasc Risk 9: 153–160, 2002
Jiang W, Babyak MA, Rozanski A, Sherwood A, O'Connor CM, Waugh RA, Coleman RE, Hanson MW, Morris JJ, Blumenthal JA: Depression and increased myocardial ischemic activity in patients with ischemic heart disease. Am Heart J 146: 55–61, 2003
Hibbeln JR: Fish consumption and major depression. Lancet 351: 1213, 1998
Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Lehttonen J, Vartianen E: Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52: 529–531, 2001
Edwards R, Peet M, Shay J, Horrobin DF: Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affective Disord 48: 149–155, 1998
Peet M, Murphy B, Shay J, Horrobin DF: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatr 43: 315–319, 1998
Maes M, Delanhe CA, Altamura C, Neels H, Meltzer HY: Lowered polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatr Res 5: 273–291, 1999
Mamalakis G, Tornaritis M, Kafatos A: Depression and adipose essential polyunsaturated fatty acids. Prostaglandins, Leuks, EFA 67: 311–318, 2002
Nemets B, Stahl Z, Bekmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatr 159: 477–479, 2002
Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoic acid in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatr 59: 913–919, 2002
Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: Omega-3 fatty acids in bipolar disorder: A preliminary double blind, placebo-controlled trial. Arch Gen Psychiatr 56: 407–412, 1999
Hibbeln JR: Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affective Disord 69: 15–29, 2002
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, Breteler MMB: Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology 59: 1915–1921, 2002
Kris-Etherton PM, Harris WS, Appel LJ: Omega-3 fatty acids and car-diovascular disease: New recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23: 151–152, 2003
Simopoulos AP, Leaf A, Salem N: Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 43: 127–130, 1999
Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, et al.: AHA Dietary Guidelines Revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation 102: 2284–2299, 2000
Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106: 2747–2757, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holub, D.J., Holub, B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol Cell Biochem 263, 217–225 (2004). https://doi.org/10.1023/B:MCBI.0000041863.11248.8d
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000041863.11248.8d